Outlook Therapeutics Inc. (OTLK)
NASDAQ · Healthcare
Outlook Therapeutics Inc. Operating Income 2015–2025
Outlook Therapeutics Inc. annual/quarterly operating income history and growth rate from 2015 to 2025. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Outlook Therapeutics Inc. operating income for the quarter ending June 30, 2025 was -15.7 M, a 179.03% increase year-over-year.
- Outlook Therapeutics Inc. operating income for the twelve months ending June 30, 2025 was -39.4 M, a 60.20% increase year-over-year.
- Outlook Therapeutics Inc. annual operating income for 2025 was -67.1 M, a 84.75% increase from 2019.
- Outlook Therapeutics Inc. annual operating income for 2019 was -36.3 M, a 22.45% increase from 2018.
- Outlook Therapeutics Inc. annual operating income for 2018 was -29.6 M, a 17.38% decrease from 2017.
- Outlook Therapeutics Inc. annual operating income for 2017 was -35.9 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Outlook Therapeutics Inc. Operating Income — FAQ
Outlook Therapeutics Inc. (OTLK) operating income over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is Outlook Therapeutics Inc.'s operating income?
Outlook Therapeutics Inc. (OTLK) reported operating income of -$67M for fiscal 2025.
Where can I see OTLK's operating income history?
The chart and table above show Outlook Therapeutics Inc.'s operating income by year and by quarter, including the growth rate.